Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Oct. 31, 2025	Oct. 31, 2024
Operating Activities
Net income (loss)	$ 197.4	$ 160.5
Adjustments to reconcile net income (loss) to net cash provided by (used for) operations:
Depreciation	178.1	145.2
Amortization	100.4	111.8
Share-based compensation expense	17.9	15.8
Loss (gain) on divestitures – net	0.0	260.8
Deferred income tax expense (benefit)	64.0	23.9
Other noncash adjustments – net	28.3	30.1
Changes in assets and liabilities, net of effect from acquisition and divestitures:
Trade receivables	(56.6)	(68.5)
Inventories	(145.6)	(54.4)
Other current assets	77.0	25.7
Accounts payable	(161.0)	(83.4)
Accrued liabilities	55.3	19.8
Income and other taxes	(16.9)	(4.6)
Other – net	(2.4)	(5.6)
Net Cash Provided by (Used for) Operating Activities	335.9	577.1
Investing Activities
Additions to property, plant, and equipment	(150.6)	(210.7)
Proceeds from disposal of property, plant, and equipment	13.1	0.0
Collateral pledged for derivative cash margin accounts	(52.8)	(14.9)
Other – net	0.3	(0.1)
Net Cash Provided by (Used for) Investing Activities	(190.0)	(225.7)
Financing Activities
Short-term borrowings (repayments) – net	87.4	(121.6)
Quarterly dividends paid	(231.2)	(226.5)
Purchase of treasury shares	(5.0)	(2.7)
Other – net	(2.9)	(12.9)
Net Cash Provided by (Used for) Financing Activities	(151.7)	(363.7)
Effect of exchange rate changes on cash	(1.3)	(0.5)
Net increase (decrease) in cash and cash equivalents	(7.1)	(12.8)
Cash and cash equivalents at beginning of period	69.9	62.0
Cash and cash equivalents at end of period	$ 62.8	$ 49.2